… Meet us in Singapore … Trendlines Medical Singapore forms R&D partnership … See the Q3 10 companies to watch report … BioFishency wins Fishtech Awards … Check out our new website …
Trendlines Medical Singapore and A*ccelerate establish a partnership to jointly develop and commercialize medical technologies.
Chairman and CEO Todd Dollinger and Trendlines Medical Singapore CEO Eric Loh were interviewed on the The Breakfast Huddle podcast.
NextInsight reported about the “two firsts” we achieved in Q3 2018.
The BioTuesday’s article focuses on Trendlines’ 11 years of progressive growth and its very hands-on approach.
FruitSpec completed successful field studies using its hyperspectral machine vision technology for accurate fruit yield estimates/projections.
Here is our 10 Companies to Watch report for Q3 2018.
… Trendlines wins Singaporean award … ApiFix completes 250 procedures … Leviticus Cardio completes study …
ApiFix announced its technology has now been used to treat more than 250 young patients diagnosed with progressive scoliosis.
Leviticus Cardio successfully completed a 90-day chronic animal study to evaluate its Coplanar Energy Transfer (CET) technology in combination with a commercial heart pump.